Inovio Pharmaceuticals (INO) hikeson DARPA designation

Inovio Pharmaceuticals, Inc. INO gained 6% to $9.63 as the company reported that it has been selected by the DARPA to lead a $45-million program to expedite development of novel products to prevent and treat disease caused by Ebola. Share volume was 813,000, compared to an all-day average of 800,000